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ABSTRACT 
Background Primary ciliary dyskinesia is associated with progressive lung damage eventually 
culminating in chronic infection with Pseudomonas aeruginosa. Lung damage is usually evaluated by 
high-resolution computed tomography (HRCT). 
Objective To evaluate whether the presence of HRCT abnormalities and of Pseudomonas aeruginosa 
infection was better predicted by spirometry or plethysmography. 
Methods A cross-sectional study was performed in consecutive patients diagnosed with PCD. 
All patients underwent sputum culture, spirometry, plethysmography and HRCT over a 48 hour 
period. 
Results Fifty patients (26 children) were studied. Pseudomonas aeruginosa infection was found in 
40% of the patients and bronchiectasis in 88%. There was a significant correlation between infection 
with Pseudomonas aeruginosa and extent of bronchiectasis (p=0.009, r=0.367) and air-trapping 
(p=0.03 r=0.315). Moreover, there was a significant association between infection with Pseudomonas 
aeruginosa and RV values > 150% (p=0.04) and RV/TLC ratio > 140% (p=0.001), but not between 
infection with Pseudomonas aeruginosa and FEV1< 80%, or FEF25-75% < 70%, or FEV1/FVC  < 70%  
(< 80% in children). Severity of the total lung impairment on chest HRCT inversely correlated with 
FEV1 (p= 0.02; r= -0.322), FVC (p= 0.007; r= -0.376) and directly correlated with RV (p= 0.003; 
r=0.423), and RV/TLC (p < 0.001; r= 0.513). 
Conclusions Plethysmography predicts better than spirometry HRCT abnormalities, and might be a 
useful test to reduce the number of HRCT scans performed in PCD. 
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INTRODUCTION 
Primary ciliary dyskinesia (PCD) is a rare (1:15-30 000 live births) genetic disorder, and nearly half 
the patients have situs inversus.[1] Abnormal motility of respiratory cilia and impaired mucociliary 
clearance result in a myriad of clinical manifestations including recurrent infections of the upper 
and lower airways, eventually causing permanent parenchymal damage, and progressive decline in 
lung function. 
Chest high-resolution computed tomography (HRCT) has become the method of choice to evaluate 
structural airway changes,[2]  and is used in conjunction with clinical and physiological findings in 
a number of chronic respiratory diseases  including PCD.[3, 4]   
However, there is little evidence that regular computed tomography scans affect outcome in PCD 
[5] and the potential high lifetime cumulative radiation exposure should be considered.[6, 7]  
Guidelines suggest that age-appropriate lung function tests should be performed at every visit in 
cooperative children [1, 5, 8] since it has been shown that the severity of structural abnormalities 
may correlate with impairment of pulmonary function, as reflected by first second forced expired 
volume (FEV1).[3, 4] However, a decreased FEV1 is not indicative of the site of airway obstruction 
[9] and, as in cystic fibrosis, there are many reasons to believe that there is small airway disease 
early on in the course of PCD.[10] Furthermore, spirometry does not detect small airways disease 
until the damage is very advanced. Since small airways obstruction may lead to an increase of both 
residual volume (RV) and RV/total lung capacity (TLC) ratio,[9]  we hypothesised that air trapping 
manifest by a raised RV and RV/TLC ratio may be more sensitive than spirometry to structural 
changes as shown by HRCT in PCD. The aim of the study was to determine the correlations 
between HRCT abnormalities and dynamic or static lung function parameters in patients with PCD, 
in order to assess their use as monitoring tools of the disease.[11]   
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MATERIALS AND METHODS 
Subjects  
Between March 2008 and May 2010, we enrolled consecutively diagnosed PCD patients age > 6 
years followed up in the Department of Paediatrics of the University of Pisa. PCD was diagnosed 
on standard criteria (below) and we obtained sputum, cough swab or pharyngeal aspirate cultures, 
spirometry and body plethysmography, and a high resolution computed tomography (HRCT) of the 
chest. Pharyngeal aspirate was obtained in uncooperative children after an overnight fast using a 
disposable catheter connected to a mucus extractor inserted into the mouth to a depth of 7 to 10 cm 
and drawn back while applying gentle suction. 
Informed consent was obtained from adult patients or from the parents of children with PCD and 
the study protocol was approved by the Hospital Ethical Committee of Pisa. 
 
Ciliary motion analysis and ultrastructural studies 
 
Samples obtained from the inferior turbinate using a cytology brush (Microvasive, Milford, MA, 
USA) were suspended in 2 ml of Medium 199 fluid cell culture, in 2 ml of normal saline or in 5 ml 
of a PBS/antibiotic 2% solution, respectively, for immediate light-microscopic, for transmission 
electron microscopy (TEM) evaluation, and for cell cultures.[12] Ciliary morphology, motion 
pattern, beat frequency, ultrastructural studies, and ciliary activity after ciliogenesis in culture were 
evaluated according to standardised methodology.[13-15]  
Ciliary motion analysis, ultrastructural assessment, and cultures were performed by different 
operators each one blind to the results obtained by the others. 
 
Lung Function 
Flow-volume curves and body plethysmography were obtained utilizing standard ATS 
methodology.[16, 17] Subjects were tested using a Master Screen Body equipment; Jaeger, 
Wuerzburg, Germany). FEV1 , FVC (Forced Vital Capacity), FEF25-75% (Forced Expiratory Flow 
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between 25% and 75% of FVC), RV, TLC and RV/TLC were expressed as percentage of predicted 
values .[18] Lung function studies were all performed on the same day, within two days of the 
HRCT. 
 
Computed Tomographic scanning of chest 
In all patients chest HRCT was performed either following the conventional 1 mm slice thickness 
10 mm spacing protocol or applying a retroreconstruction algorithm after a spiral CT acquisition.  
No intravenous contrast was given and no anaesthesia was needed. All images were evaluated by 
the same radiologist who was blinded to the clinical data and scored using a modified Bhalla 
system,[19][*] which includes severity of bronchiectasis (score 0-3) and extent of bronchiectasis 
(score 0-3), mucous plugging (score 0-3), peribronchial thickening (score 0-3), parenchymal 
abnormalities, such as atelectasis (score 0-3) and focal air-trapping (score 0-3). Bronchiectasis was 
identified according to standard criteria.[20] 
Thus, a severity class (from 1 to 3) for total lung impairment was obtained (class of severity 1 for 
total score of 0-6, class 2 for total score of 7-12, class 3 for total score of 13-18). 
 
Soft computing analysis of data 
The Principal Component Analysis (PCA) methodology was applied to display data. PCA is a 
mathematical procedure aimed to scale the data in a three-dimensional uncorrelated space, in order 
to display statistical meaningful differences among the original variables.[21] 
Data were analyzed with soft computing methodologies. Basic elements of soft computing and the 
application of intelligent control have been recently introduced.[22] The term soft computing 
denotes methodologies that seek to integrate arithmetical computing, reasoning and decision 
making into a framework trading off precision and uncertainty. The methodologies used are fuzzy 
logic, neural networks (NNs) and genetic algorithms and programming.[23] Soft computing-based 
models are capable of analyzing complex medical data, exploiting meaningful relationships in a 
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data set to help physicians in the diagnosis, treatment and prediction of the clinical outcomes. 
The soft computing-based modelling approach was applied to either or both of flow-volume data 
and body plethysmography in order to develop a model predictive of chest HRCT scores. The 
model was identified by means of a self-organizing artificial neural network (ANN). ANNs are 
mathematical models, which distributed adaptable parameters are modified through a learning 
process according to real data. ANNs are able to deal with imprecision, uncertainty, partial truth of 
the biological knowledge, mimicking the processing capabilities of human mind.                                    
Kohonen self-organizing map (KSOM) predictive models were identified to classify chest HRCT 
scores, (total lung impairment, severity of bronchiectasis, extent of bronchiectasis, peribronchial 
thickening, mucous plugging, atelectasis, focal air-trapping), starting from flow-volume parameters  
(FEV1, FVC, FEV1/FVC, FEF25-75%) and body plethysmography data (RV, TLC, RV/TLC). KSOM 
is a two-dimensional ANN-based model able to solve classification tasks exploiting structures in the 
data through an unsupervised learning process.[24] 
 
Statistical analyses 
There are no data in the published literature to inform a power calculation, so the sample size was 
opportunistic. Baseline variables were expressed as group mean ± SD or as median and interquartile 
range when the variables were non-normally distributed. Correlations between continuous non-
normally distributed variables were assessed using Spearman's rank correlation test. The chi-
squared test was used to evaluate the association between Pseudomonas aeruginosa (alone or with 
other bacterial infection) and RV > 150%, RV/TLC ratio >140%, and FEV1 < 80% or FEF 25-75 < 
70%  percent of predicted, respectively. The association between Pseudomonas aeruginosa and 
FEV1/FVC less than 80% predicted for children and less than 70% predicted for adults was also 
evaluated. These cut-offs were selected because they were previously demonstrated to correlate 
with air-trapping on HRCT in children.[25] 
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 A p-value < 0.05 was considered statistically significant. All statistical calculations were performed 
using SPSS version 18.0 software for Windows (SPSS, Inc, Chicago, IL) for personal computers. 
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RESULTS  
Fifty patients were studied. Twenty-three had situs inversus, 26 were children (19 males and 7 
females, age range: 6 –17 years, median 11 years; IQR 5.25) and 24 adults (9 males and 15 females, 
age range: 18–47 years, median 30.5 years; IQR 9.5).  
Infection with Pseudomonas aeruginosa (with or without other bacteria) was found in 20 (40.0%) 
patients, 7 of whom were children (27% infected). Other infecting organisms (Serratia marcescens, 
Rhodococcus equi, Streptococcus pneumoniae, Staphylococcus aureus, Enterobacter cloacae, 
Streptococcus pyogenes, Alcaligenes xylosoxidans) were found in 12 (24.0%) subjects.  
FEV1 ranged from 31% to 136% of predicted (mean 85.3; SD 24.6). FVC ranged from 47% to 
138% of predicted (mean 93.4; SD 18.5). FEF25-75 ranged from 10% to 151% of predicted (mean 
63.2; SD 34.4). RV ranged from 83% to 397% (mean 196.5; SD 69.4). TLC ranged from 85% to 
174% (mean 119.2; SD 16.7). RV/TLC ranged from 91% to 305% (mean 161.0; SD 45.6). 
HRCT Bhalla score was 0 in 3 subjects, 1 in 12 (Image 1), 2 in 27(Images 2a, 2b, 4, 6), and 
3(Images 3a, 3b,5) in the remaining 8 subjects. Bronchiectasis was documented in 44 (88%) 
patients, 21 of whom were children. Bronchiectasis was present in multiple lobes in 36/44 (82 %) 
subjects. The distribution of bronchiectasis is detailed in table 1.    
Patient age was inversely correlated with percent predicted FEV1 (p=0.006; r=-0.384), FVC 
(p=0.04; r=-0.295), FEF25-75% (p=0.01; r=-0.362), and FEV1/FVC (p=0.02 r=-0.336) but surprisingly 
not with RV and RV/TLC. 
There was a significant correlation between infection with Pseudomonas aeruginosa and extent of 
bronchiectasis (p=0.009, r=0.367) and air-trapping (p=0.03 r=0.315). Moreover, there was a 
significant association between infection with Pseudomonas aeruginosa and RV values > 150% 
(p=0.04) and RV/TLC ratio >140% (p=0.001), but not between infection with Pseudomonas 
aeruginosa and FEV1<80%, or FEF25-75% <70%, or FEV1/FVC < 70% (<80% in children). 
There were significant correlations between HRCT scores and physiological parameters. In 
particular, severity of the total lung impairment on chest HRCT inversely correlated with FEV1  
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(p= 0.02; r= -0.322), FVC (p= 0.007; r= -0.376), but not with FEF 25-75 or FEV1/FVC, and directly 
correlated with RV (p= 0.003; r=0.423) (Fig. 1), and RV/TLC (p < 0.001; r= 0.513) (Fig. 2), but not 
with TLC.  Among HRCT parameters, severity and extent of bronchiectasis and air-trapping were 
inversely correlated with spirometry and positively correlated with plethysmography indexes 
(shown in detail in Table 2) 
Moreover, there was a direct correlation between the age of the patients and total lung impairment 
on chest HRCT (p=0.002; r=0.425), as well as severity (p=0.004; r=0.404) and extent of 
bronchiectasis (p<0.001; r=0.510), but not with focal air-trapping scores or other parameters.  
PCA performed using the body plethysmography data is depicted in  Figure 3, which shows three 
dimensional scatter plots of the first three principal components corresponding to the body 
plethysmography variables (RV, TLC, and RV/TLC ratio), after the removal of an outlier. Each 
scatter plot shows the differences between scores 1 and 3 for focal air-trapping (Fig 3a), atelectasis 
(Fig 3b), extent of bronchiectasis (Fig 3c), and total lung impairment (Fig. 3d) respectively. The 
PCA topological study allows focal air-trapping severity, atelectasis and the extent of bronchiectasis 
to be visually discriminated, although the clusters overlap. The analysis does not allow severity of 
bronchiectasis, peribronchial thickening and mucous plugging to be discriminated. The PCA 
topological study of flow-volume data does not permit any discrimination of chest HRCT scores. 
The PCA topological study does not identify patients with Pseudomonas aeruginosa infection. 
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DISCUSSION 
Statement of principal findings 
To our knowledge this is the largest dataset of contemporaneous spirometry, plethysmography and 
HRCT in patients with PCD to date. HRCT was performed in all patients aged six years or older 
because it is known that from this age a many patients already have some degree of bronchiectasis 
[26] and, furthermore, from this age patients can both cooperate with the procedure and be able to 
perform reproducible lung function testing.[27] 
We show that soft computing modelling based on plethysmography, but not spirometry, is sensitive 
to a range of HRCT abnormalities. Reduction in lung function associated with bronchiectasis has 
been previously reported both in cross-sectional and longitudinal studies [11, 28] in patients with 
PCD. However, we report for the first time that RV and RV/TLC ratio is associated with the 
severity of air trapping, atelectasis, and extent of bronchiectasis and with Pseudomonas aeruginosa 
infection. Hence follow-up of PCD patients may be preferable with plethysmography rather than 
simple spirometry.  
 
Strengths and weaknesses of the study                                                                                                       
Our study has a number of strengths. First the completeness of ascertainment, since all  patients 
performed all the tests, obviating selection bias. Second all the evaluations were done within 48 
hours. Third the objective analytical techniques using soft computing and objective mathematical 
analyses greatly reduces the chance of investigator bias. We accept that the study would have been 
stronger with longitudinal data and a second cohort on which to validate our findings.   
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Strengths and weaknesses in relation to other studies 
 
In our study group the vast majority of adults and 80% of the children had bronchiectasis and, as 
previously reported, half of the adults [28] and approximately one third of the children had chronic 
Pseudomonas aeruginosa infection. The later was associated with air-trapping, as previously 
documented in young children with cystic fibrosis.[29] Focal air-trapping, which  indicates small 
airways disease,  probably starts early and our results documents that static lung volume evaluation 
can detect this even in younger patients. This finding lends further support to the hypothesis that 
peripheral lung damage may be an early event in PCD.[10]  
It has been recently suggested that even the youngest patients already have irreversible lung damage 
[11] and that bronchiectasis, reduction in lung flows and increased RV and RV/TLC can be present 
in PCD patients as young as less than 3 years.[30] We were not able to determine this, because we 
could not study very young children with PCD. 
 
Meaning of the study 
 
Our findings suggest that lung disease in PCD begins early and that it is better identified at least in 
school age children and adults by the finding of air-trapping or HRCT, rather than spirometry.  In 
previous studies of adults and children with PCD, HRCT scores were shown to be related to 
spirometry.[3, 4] Our results do not confirm this but suggest that plethysmography is a much more 
sensitive test. 
CT scanning of the chest has become a popular tool to monitor patients with cystic fibrosis,[31] a 
disease that has similarities with PCD. However, no study has evaluated the impact of such 
monitoring on health outcomes or on clinical decision making in either PCD or indeed cystic 
fibrosis patients. Moreover, there are concerns on the uncritical use of high-tech medical imaging 
and on the potential harm of repeated radiologic exposures particularly in children with life-long 
diseases.[6, 7] Consequently, careful thought is needed before requesting repeated chest CT scans. 
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By contrast a detailed evaluation of lung volumes is only limited by the availability of the 
equipment, and this is usually not a problem in centres that care for these patients. 
 
 
Unanswered questions and future research                                                                                           
Even though we have not studied very young subjects, from our results it is tempting to speculate 
that accumulation of secretions, in the early stages of disease, may induces primarily an obstruction 
in terminal bronchioles which may go undetected for a long period during the period of alveolar 
growth of the lung.  The consequent focal air-trapping during this phase of alveolar growth might 
lead to impaired septation, and decreased elastic recoil as has been observed in animal models.[32]  
If there were early structural changes in the distal part of the lung, this could explain why we found 
a lack of correlation between RV and RV/TLC with age, unlike for spiromery which may reflect a 
slower progressive damage to large airways with age. This hypothesis could only be proved in a 
longitudinal study in PCD patients from the newborn period, using age appropriate physiological 
techniques.  
Although our findings show the superior sensitivity of plethysmography over spirometry in 
detecting HRCT changes in PCD, the findings need to be validated in a second cohort of patients. It 
would be valuable to compare plethysmography with sophisticated assessments of distal airway 
function such as lung clearance index.[33] Longitudinal data are needed to determine which 
technique is more sensitive to a change in the patient’s condition. Finally, comparisons of 
plethysmography and spirometry in other airway diseases would be of interest. 
 
In conclusion, in this group who have a high pre-test probability of lung damage,[26] and given the 
different correlations between the various lung function parameters and HRCT derived lung disease 
scores we suggest that measurement of lung volumes rather than spirometry may be preferable in 
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the routine clinical management of PCD. Furthermore, this may reduce the number of scans used to 
monitor disease progression, although this needs testing prospectively. As with all investigations, 
HRCT should be requested only when the results are going to change the therapeutic strategy in the 
individual patient, or as part of an ethically approved, focused research protocol.[8] 
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Figure legends 
[*] : Modified Bhalla system 
Figure 1: Correlation between Residual Volume (RV) % predicted and total lung impairment 
severity score at chest high resolution computed tomography (HRCT) 
Figure 2: Correlation between Residual Volume (RV) and Total Lung Capacity (TLC) ratio (% 
predicted) and total lung impairment severity score at chest high resolution computed tomography 
(HRCT). 
Figure 3a: Three dimensional scatter plots for air-trapping score 1 (triangles), 2 (circles), 3 
(squares) in relationship with RV, TLC and RV/TLC ratio. 
Figure 3b: Three dimensional scatter plots for atelectasis score 1 (triangles), 2 (circles), 3 (squares) 
in relationship with RV, TLC and RV/TLC ratio. 
Figure 3c: Three dimensional scatter plots for bronchiectasis extension score 1 (triangles), 2 
(circles), 3 (squares) in relationship with RV, TLC and RV/TLC ratio. 
Figure 3d: Three dimensional scatter plots for total lung impairment score 1 (triangles), 2 (circles), 
3 (squares) in relationship with RV, TLC and RV/TLC ratio. 
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[*]  Scoring System HRCT  
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Lobes Right Left 
Upper 20 25 
Middle 45 11.4* 
Lower 84 70 
Lingula 6.8 * 16 
 
 
Tab. 1 Bronchiectasis distribution (%) in multiple lobes  
           * in patients with situs inversus 
 
HRCT 
parameters 
 
FEV1 FVC FEF25/75 FEV1/FVC RV TLC RV/TLC 
Severity of 
bronchiectasis 
p=0.01 
r=-0.350 
 
p=0.005 
r=-0.393 
ns ns p=0.02 
r=0.331 
ns p=0.005 
r=0.408 
Extent of 
bronchiectasis 
p=0.01 
r=-0.346 
 
p=0.01 
r=-0.356 
p=0.02 
r=-
0.316 
ns p=0.02 
r=0.336 
ns p=0.001 
r=0.459 
Peribronchial 
thickening 
ns 
 
ns ns ns ns ns ns 
Extent of mucus 
plugging 
 
ns ns ns ns ns ns ns 
Consolidation/atel
ectasis 
 
ns ns ns ns ns ns ns 
Air-trapping p=0.01 
r=-0.341 
 
ns p=0.01 
r=-
0.362 
p=0.04 
r=-0.291 
p<0.001 
r=0.728 
p=0.008 
r=0.389 
 
p<0.001 
r=0.757 
 
Table 2. Chest HRCT and functional parameters in subjects with PCD 
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Table 1. Models based on body plethysmography or spirometry variables and correct recognition 
(expressed as mean ± standard deviation) of focal air-trapping and atelectasis severity, extension of 
bronchiectasis, and total lung impairment on chest HRCT, respectively. 
 
 
 
 
 
Severity of bronchiectasis 
 
 Plethysmography Spirometry 
 Score 1 Score 2 Score 3 Score 1 Score 2 Score 3 
Score 1 94.5 ± 0.08 4± 0.21 1.5 ± 0.15 42 ± 0.19 28 ± 0.19 30 ± 0.17 
Score 2 10 ± 0.13 77.3 ± 0.19 12.7 ± 0.8 37.5 ± 0.24 32.5 ± 0.17 30 ± 0.19 
Score 3 9 ± 0.24 10 ± 0.13 81 ± 0.24 15 ± 0.24 50 ± 0.23 35 ± 0.24 
 
Atelectasis 
 
 Plethysmography Spirometry 
 Score 1 Score 2 Score 3 Score 1 Score 2 Score 3 
Score-1 66.3 ± 0.18 12.1 ± 0.12 21.6 ± 0.18 40 ± 0.37 15 ± 0.21 45 ± 0.37 
Score 2 32 ± 0.5 60.3 ± 0.13 7.7 ± 0.8 52 ± 0.21 25 ± 0.37 23 ± 0.11 
Score 3 7.3 ± 0.23 14.7 ± 0.09 78 ± 0.23 41.4 ± 0.18 20 ± 0.12 38.6 ± 0.12 
 
Extension of Bronchiectasis 
 
 Plethysmography Spirometry 
 Score 1 Score 2 Score 3 Score 1 Score 2 Score 3 
Score 1 79.3 ± 0.23 15.1 ± 0.03 5.6 ± 0.23 23 ± 0.33 63.33 ± 0.29 13 ± 0.23 
Score 2 21.7 ± 0.13 59.3 ± 0.19 19 ± 0.05 41.66 ± 0.26 28.33 ± 0.13 30.00 ± 0.17 
Score 3 6 ± 0.21 14 ± 0.13 80 ± 0.21 20 ± 0.25 25 ± 0.35 55 ± 0.28 
 
Total Score 
 
 Plethysmography Spirometry 
 Score 1 Score 2 Score 3 Score 1 Score 2 Score 3 
Score 1 80.3 ± 0.21 15.1 ± 0.26 4.6 ± 0.17 30 ± 0.18 63.33 ± 0.19 6.6 ± 0.14 
Score 2 21.7 ± 0.13 63.3 ± 0.21 15 ± 0.19 41.66 ± 0.18 23.33 ± 0.11 35.0 ± 0.16 
Score 3 6 ± 0.21 4 ± 0.25 90 ± 0.25 15 ± 0.24 10 ± 0.21 55 ± 0.26 
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Image 1: score 1 severity of bronchiectasis 
 
 
 
 
Image 2a: score 2 severity of bronchiectasis  
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Image 2b: score 2 severity of bronchiectasis 
 
 
 
  
 
 
Image 3a: score 3 severity of bronchiectasis  
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Image 3b: score 3 severity of bronchiectasis 
 
 
  
 
Image 4: total score 2 HRCT 
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Image 5: total score 3 HRCT 
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Image 6: total score 2 HRCT; score 3 severity of bronchiectasis 
 
 
 
 
 
 
 
 
 
